Business Description
Kenvue Inc
NAICS : 811490
SIC : 2842
ISIN : US49177J1025
Description
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.13 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.82 | |||||
Debt-to-EBITDA | 2.82 | |||||
Interest Coverage | 5.56 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 2.12 | |||||
Beneish M-Score | -2.67 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.9 | |||||
3-Year EBITDA Growth Rate | -4.6 | |||||
3-Year EPS without NRI Growth Rate | -2 | |||||
3-Year FCF Growth Rate | -4.5 | |||||
3-Year Book Growth Rate | -15.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 1.34 | |||||
Future 3-5Y Total Revenue Growth Rate | 2.67 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 7.28 | |||||
9-Day RSI | 18.52 | |||||
14-Day RSI | 27.44 | |||||
6-1 Month Momentum % | -3.58 | |||||
12-1 Month Momentum % | -19.23 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.99 | |||||
Quick Ratio | 0.68 | |||||
Cash Ratio | 0.19 | |||||
Days Inventory | 107.1 | |||||
Days Sales Outstanding | 49.72 | |||||
Days Payable | 124.89 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 4.47 | |||||
Dividend Payout Ratio | 0.53 | |||||
Forward Dividend Yield % | 4.46 | |||||
5-Year Yield-on-Cost % | 4.47 | |||||
3-Year Average Share Buyback Ratio | -0.5 | |||||
Shareholder Yield % | -20.91 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 56.57 | |||||
Operating Margin % | 16.24 | |||||
Net Margin % | 9.63 | |||||
FCF Margin % | 13.47 | |||||
ROE % | 11.64 | |||||
ROA % | 5.13 | |||||
ROIC % | 7.78 | |||||
ROC (Joel Greenblatt) % | 124.05 | |||||
ROCE % | 10.33 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 23.03 | |||||
Forward PE Ratio | 15.75 | |||||
PE Ratio without NRI | 15.95 | |||||
PS Ratio | 2.2 | |||||
PB Ratio | 3.24 | |||||
Price-to-Free-Cash-Flow | 16.28 | |||||
Price-to-Operating-Cash-Flow | 12.84 | |||||
EV-to-EBIT | 16.99 | |||||
EV-to-Forward-EBIT | 12.47 | |||||
EV-to-EBITDA | 13.55 | |||||
EV-to-Forward-EBITDA | 12.57 | |||||
EV-to-Revenue | 2.7 | |||||
EV-to-Forward-Revenue | 2.68 | |||||
EV-to-FCF | 20.1 | |||||
Earnings Yield (Greenblatt) % | 5.89 | |||||
FCF Yield % | 6.09 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kenvue Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 14,314.71 | ||
EPS (TTM) (€) | 0.722 | ||
Beta | 0 | ||
Volatility % | 26.1 | ||
14-Day RSI | 27.44 | ||
14-Day ATR (€) | 0.281016 | ||
20-Day SMA (€) | 17.4901 | ||
12-1 Month Momentum % | -19.23 | ||
52-Week Range (€) | 16.256 - 24.2 | ||
Shares Outstanding (Mil) | 1,914.81 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kenvue Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kenvue Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Kenvue Inc Frequently Asked Questions
What is Kenvue Inc(FRA:J4D)'s stock price today?
The current price of FRA:J4D is €16.53. The 52 week high of FRA:J4D is €24.20 and 52 week low is €16.26.
When is next earnings date of Kenvue Inc(FRA:J4D)?
The next earnings date of Kenvue Inc(FRA:J4D) is 2024-07-19 Est..
Does Kenvue Inc(FRA:J4D) pay dividends? If so, how much?
The Dividend Yield %  of Kenvue Inc(FRA:J4D) is 4.47% (As of Today), Highest Dividend Payout Ratio of Kenvue Inc(FRA:J4D) was 0.53. The lowest was 0.31. And the median was 0.31. The  Forward Dividend Yield % of Kenvue Inc(FRA:J4D) is 4.46%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |